Literature DB >> 17324352

Lymphogranuloma venereum: old pathogen, new story.

Preeti Pathela1, Susan Blank, Julia A Schillinger.   

Abstract

Lymphogranuloma venerum (LGV), an ulcerative sexually transmitted infection caused by the L serovars of Chlamydia trachomatis, has gained recent attention as a cause of hemorrhagic proctitis among men who have sex with men in North America, the United Kingdom, and Europe. It has been a rare diagnosis, and likely has not been included in the routine differential diagnosis for proctocolitis. The lack of a specific diagnostic test has complicated LGV case ascertainment. In the absence of laboratory confirmation of L serovars, physicians are advised to treat possible cases presumptively for LGV and provide medical management of sexual partners. The appearance of an ulcerative infection in sexual networks with high rates of HIV coinfection may forewarn of increased HIV transmission; interruption of disease transmission remains a priority for medical providers and the public health community.

Entities:  

Year:  2007        PMID: 17324352     DOI: 10.1007/s11908-007-0010-7

Source DB:  PubMed          Journal:  Curr Infect Dis Rep        ISSN: 1523-3847            Impact factor:   3.663


  25 in total

Review 1.  Lymphogranuloma venereum.

Authors:  D Mabey; R W Peeling
Journal:  Sex Transm Infect       Date:  2002-04       Impact factor: 3.519

2.  Lymphogranuloma venereum in the United Kingdom.

Authors:  P French; C A Ison; N Macdonald
Journal:  Sex Transm Infect       Date:  2005-04       Impact factor: 3.519

3.  Lymphogranuloma venereum in the industrialised world.

Authors:  Susan Blank; Julia A Schillinger; Dawn Harbatkin
Journal:  Lancet       Date:  2005 May 7-13       Impact factor: 79.321

4.  A multiplexed real-time PCR assay for rapid detection of Chlamydia trachomatis and identification of serovar L-2, the major cause of Lymphogranuloma venereum in New York.

Authors:  Tanya A Halse; Kimberlee A Musser; Ronald J Limberger
Journal:  Mol Cell Probes       Date:  2006-03-06       Impact factor: 2.365

Review 5.  Genital elephantiasis and sexually transmitted infections - revisited.

Authors:  Somesh Gupta; C Ajith; Amrinder J Kanwar; Virendra N Sehgal; Bhushan Kumar; Uttam Mete
Journal:  Int J STD AIDS       Date:  2006-03       Impact factor: 1.359

6.  The association of herpes simplex virus type 2 (HSV-2), Haemophilus ducreyi, and syphilis with HIV infection in young men in northern Thailand.

Authors:  K E Nelson; S Eiumtrakul; D Celentano; I Maclean; A Ronald; S Suprasert; D R Hoover; S Kuntolbutra; J M Zenilman
Journal:  J Acquir Immune Defic Syndr Hum Retrovirol       Date:  1997-12-01

7.  Association between HIV-1 infection, the etiology of genital ulcer disease, and response to syndromic management.

Authors:  Prashini Moodley; Patrick D J Sturm; Trusha Vanmali; David Wilkinson; Cathy Connolly; A Willem Sturm
Journal:  Sex Transm Dis       Date:  2003-03       Impact factor: 2.830

8.  Resurgence of lymphogranuloma venereum in Western Europe: an outbreak of Chlamydia trachomatis serovar l2 proctitis in The Netherlands among men who have sex with men.

Authors:  Rutger F Nieuwenhuis; Jacobus M Ossewaarde; Hannelore M Götz; Jan Dees; H Bing Thio; Maarten G J Thomeer; Jan C den Hollander; Martino H A Neumann; Willem I van der Meijden
Journal:  Clin Infect Dis       Date:  2004-09-08       Impact factor: 9.079

9.  Primary and secondary syphilis--United States, 2002.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2003-11-21       Impact factor: 17.586

10.  Rectal lymphogranuloma venereum, France.

Authors:  Magid Herida; Patrice Sednaoui; Elisabeth Couturier; Didier Neau; Maïthe Clerc; Catherine Scieux; Gerard Kreplak; Véronique Goulet; Françoise F Hamers; Bertille de Barbeyrac
Journal:  Emerg Infect Dis       Date:  2005-03       Impact factor: 6.883

View more
  7 in total

1.  Absence of lymphogranuloma venereum infection among high-risk men who have sex with men in Lima, Peru.

Authors:  Jesse L Clark; Benjamin Espinosa; Segundo R Leon; Eric R Hall; Hector J Salvatierra; Carlos F Cáceres; Jeffrey D Klausner; Thomas J Coates
Journal:  Int J STD AIDS       Date:  2008-06       Impact factor: 1.359

Review 2.  Dermatologic care for lesbian, gay, bisexual, and transgender persons: Epidemiology, screening, and disease prevention.

Authors:  Howa Yeung; Kevin M Luk; Suephy C Chen; Brian A Ginsberg; Kenneth A Katz
Journal:  J Am Acad Dermatol       Date:  2019-03       Impact factor: 11.527

3.  Lymphogranuloma venereum proctosigmoiditis is a mimicker of inflammatory bowel disease.

Authors:  Marlene Gallegos; Dawn Bradly; Shriram Jakate; Ali Keshavarzian
Journal:  World J Gastroenterol       Date:  2012-07-07       Impact factor: 5.742

4.  Use of real-time PCR as an alternative to conventional genotyping methods for the laboratory detection of lymphogranuloma venereum (LGV).

Authors:  Evonne N Woodson; Samantha S Katz; Sheree S Mosley; Damien C Danavall; Katherine E Bowden; Kai-Hua Chi; Brian H Raphael
Journal:  Diagn Microbiol Infect Dis       Date:  2021-08-27       Impact factor: 2.803

5.  The association between lymphogranuloma venereum and HIV among men who have sex with men: systematic review and meta-analysis.

Authors:  Minttu M Rönn; Helen Ward
Journal:  BMC Infect Dis       Date:  2011-03-18       Impact factor: 3.090

Review 6.  The Epidemiological Impact of STIs among General and Vulnerable Populations of the Amazon Region of Brazil: 30 years of Surveillance.

Authors:  Luiz Fernando Almeida Machado; Ricardo Roberto de Souza Fonseca; Maria Alice Freitas Queiroz; Aldemir Branco Oliveira-Filho; Izaura Maria Vieira Cayres-Vallinoto; Antonio Carlos Rosário Vallinoto; Marluísa de Oliveira Guimarães Ishak; Ricardo Ishak
Journal:  Viruses       Date:  2021-05-07       Impact factor: 5.048

7.  Discovering and differentiating new and emerging clonal populations of Chlamydia trachomatis with a novel shotgun cell culture harvest assay.

Authors:  Naraporn Somboonna; Sally Mead; Jessica Liu; Deborah Dean
Journal:  Emerg Infect Dis       Date:  2008-03       Impact factor: 6.883

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.